3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
17
Prostate Cancer Metastatic
3
Neoplasms
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Carcinoma, Transitional Cell
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Metastatic Breast Cancer With Intracranial Metastases
1
Malignant Solid Tumor - Malignant Nervous System Neoplasm
1
Lymphadenopathy
1
Hormone-Resistant Prostate Cancer
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
fludarabine phosphate
16
Peripheral Blood Stem Cell Transplantation
16
Cyclophosphamide
16
Mycophenolic Acid
14
Whole-Body Irradiation
13
Cyclosporine
12
Busulfan
12
Tacrolimus
11
Methotrexate
10
Antilymphocyte Serum
9
Etoposide
7
Cyclosporins
7
Melphalan
6
Sirolimus
5
Radiotherapy
5
Cytarabine
5
Filgrastim
4
Cord Blood Stem Cell Transplantation
4
ruxolitinib
3
Rituximab
3
Granulocyte Colony-Stimulating Factor
3
Alemtuzumab
3
thymoglobulin
2
sargramostim
2
Pentostatin
2
Methylprednisolone
2
Flow Cytometry
2
Carmustine
2
Carboplatin
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic-Myeloproliferative Diseases
×
cabazitaxel
×
Clear all
No trials found.